{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:16:05Z","timestamp":1759342565379,"version":"3.38.0"},"reference-count":119,"publisher":"JLE","issue":"4","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.nephro.2010.03.002","type":"journal-article","created":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T08:44:47Z","timestamp":1271407487000},"page":"258-271","source":"Crossref","is-referenced-by-count":4,"title":["Syndromes h\u00e9molytiques et ur\u00e9miques de l\u2019adulte"],"prefix":"10.1684","volume":"6","author":[{"given":"Alexandre","family":"Hertig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Ridel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Rondeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2010.03.002_bib1","doi-asserted-by":"crossref","unstructured":"Niaudet P. Syndrome h\u00e9molytique et ur\u00e9mique de l\u2019enfant. EMC (Elsevier Masson SAS, Paris), P\u00e9diatrie-Maladies infectieuses, 4-084-D-15, 2004.","DOI":"10.1016\/j.emcped.2004.08.001"},{"key":"10.1016\/j.nephro.2010.03.002_bib2","doi-asserted-by":"crossref","unstructured":"Coppo P, Vernant JP, Veyradier A, Fr\u00e9meaux-Bacchi V, Mira JP, Guidet B, et al. Purpura thrombotique thrombocytop\u00e9nique et autres syndromes de microangiopathie thrombotique. EMC (Elsevier Masson SAS, Paris), H\u00e9matologie, 13-020-D-10, 2005.","DOI":"10.1016\/j.emch.2004.12.002"},{"key":"10.1016\/j.nephro.2010.03.002_bib3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.5858\/2003-127-834-TTPAHU","article-title":"Thrombotic thrombocytopenic purpura and haemolytic uremic syndrome are distinct pathologic entities","volume":"127","author":"Hosler","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nephro.2010.03.002_bib5","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1056\/NEJMcp053024","article-title":"Thrombotic thrombocytopenic purpura","volume":"354","author":"George","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.ki.5001535","article-title":"The molecular biology of thrombotic microangiopathy","volume":"70","author":"Tsai","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.03.002_bib7","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2010.03.002_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.nephro.2010.03.002_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","article-title":"A classification of haemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders","volume":"70","author":"Besbas","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.03.002_bib10","first-page":"71","article-title":"Clinicopathologic features of thrombotic thrombocytopenic purpura","volume":"24","author":"Kwaan","year":"1987","journal-title":"Semin Hematol"},{"key":"10.1016\/j.nephro.2010.03.002_bib11","unstructured":"Galbusera M, Noris M, Rossi C, Orisio S, Caprioli J, Ruggeri Z, et al. Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombo."},{"key":"10.1016\/j.nephro.2010.03.002_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/(SICI)1098-1101(1998)13:3<120::AID-JCA5>3.0.CO;2-E","article-title":"Thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome: diagnosis and management","volume":"13","author":"George","year":"1998","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.nephro.2010.03.002_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0882-4010(88)90024-1","article-title":"Purified verotoxins of Escherichia coli 0157. H7\u00a0decrease prostacyclin synthesis by endothelial cells","volume":"5","author":"Karch","year":"1988","journal-title":"Microb Pathog"},{"key":"10.1016\/j.nephro.2010.03.002_bib14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1056\/NEJM197804272981702","article-title":"Hemolytic uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes","volume":"298","author":"Koster","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1128\/IAI.18.3.775-779.1977","article-title":"Vero response to a cytotoxin of Escherichia coli","volume":"18","author":"Konowalchuk","year":"1977","journal-title":"Infect Immun"},{"key":"10.1016\/j.nephro.2010.03.002_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(83)91795-6","article-title":"Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools","volume":"1","author":"Karmali","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2010.03.002_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000187761","article-title":"Verotoxin-binding in human renal sections","volume":"66","author":"Lingwood","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2010.03.002_bib18","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI26007","article-title":"Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice","volume":"115","author":"Motto","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nephro.2010.03.002_bib19","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1182\/blood.V95.11.3396","article-title":"Binding and transfer of verototoxin by polynuclear leukocytes in hemolytic uremic syndrom","volume":"95","author":"Te Loo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.03.002_bib20","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0272-6386(98)70084-8","article-title":"Familial haemolytic-uremic syndrome in three generations","volume":"32","author":"Petermann","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.03.002_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00007890-200008150-00029","article-title":"Clopidogrel-associated thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome in a kidney\/pancreas transplant recipient","volume":"70","author":"Chinnakotla","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2010.03.002_bib22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1055\/s-0037-1615885","article-title":"Von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"82","author":"Furlan","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.nephro.2010.03.002_bib23","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ndt\/15.8.1112","article-title":"Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura: new insights into underlying biochemical mechanism","volume":"15","author":"Furlan","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.03.002_bib24","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(88)92287-8","article-title":"Lytic antiendothelial cell antibodies in haemolytic-uremic syndrome","volume":"2","author":"Leung","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2010.03.002_bib26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1523-1755.1998.00860.x","article-title":"TTP genetically determined?","volume":"53","author":"Noris","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.03.002_bib27","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0272-6386(12)81065-1","article-title":"Familial hemolytic-uremic syndrome and homozygous factor H deficiency","volume":"24","author":"Pichette","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.03.002_bib28","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1681\/ASN.V9122318","article-title":"Human complement factor H deficiency associated with hemolytic uremic syndrome","volume":"9","author":"Rougier","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib29","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(03)14777-0","article-title":"Complement dysregulation in haemolytic ureamic syndrome","volume":"362","author":"Bonnardeaux","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2010.03.002_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-005-0003-2","article-title":"Atypical haemolytic uremic syndrome and mutations in complement regulator genes","volume":"27","author":"Dragon-Durey","year":"2005","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.nephro.2010.03.002_bib31","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","article-title":"Familial haemolytic uraemic syndrome and an MCP mutation","volume":"362","author":"Noris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2010.03.002_bib32","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial haemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nephro.2010.03.002_bib33","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1681\/ASN.2005101051","article-title":"Genetic and functional analyses of membrane cofactor (CD46) mutations in atypical hemolytic uremic syndrome","volume":"17","author":"Fremeaux-Bacchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","article-title":"The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat","volume":"12","author":"Caprioli","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib35","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.nephro.2010.03.002_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","article-title":"Heterozygous and homozygous factor H deficiencies associated with haemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16\u00a0cases","volume":"15","author":"Dragon-Durey","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical haemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1471-4906(01)01972-X","article-title":"Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?","volume":"22","author":"Zipfel","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.nephro.2010.03.002_bib39","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in haemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nephro.2010.03.002_bib40","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V60.4.1030.1030","article-title":"Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells","volume":"60","author":"Burns","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.03.002_bib41","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib42","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1681\/ASN.V1061234","article-title":"Unrecognized pattern of von Willebrand factor abnormalities in hemolytic and uremic syndrome and thrombotic thrombocytopenic purpura","volume":"10","author":"Galbusera","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib43","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.20051732","article-title":"Systemic antithrombotic effects of ADAMTS13","volume":"203","author":"Chauhan","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib44","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood-2004-12-4856","article-title":"Thrombospondin-1\u00a0controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13","volume":"107","author":"Bonnefoy","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.03.002_bib45","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1182\/blood-2002-12-3796","article-title":"ADAMTS13\u00a0gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity","volume":"101","author":"Savasan","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.03.002_bib46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-128-7-199804010-00004","article-title":"Thrombotic thrombocytopenic purpura associated with ticlopidine: a review of 60\u00a0cases","volume":"128","author":"Bennett","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib47","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/0140-6736(91)91383-6","article-title":"Thrombotic thrombocytopenic purpura related to ticlopidine","volume":"337","author":"Page","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2010.03.002_bib48","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200006153422402","article-title":"Thrombotic thrombocytopenic purpura associated with clopidogrel","volume":"342","author":"Bennett","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib49","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1182\/blood-2005-03-0848","article-title":"Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11\u00a0cases","volume":"106","author":"Fakhouri","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.03.002_bib50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1055\/s-2007-1005108","article-title":"Thrombotic thrombocytopenic purpura: a thirty-year review","volume":"6","author":"Petitt","year":"1980","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.nephro.2010.03.002_bib51","first-page":"381","article-title":"The hemolytic-uremic syndrome: prognostic significance of neurological abnormalities","volume":"40","author":"Bos","year":"1985","journal-title":"Helv Paediatr Acta"},{"key":"10.1016\/j.nephro.2010.03.002_bib52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000167066","article-title":"Renal involvement in patients with thrombotic thrombocytopenic purpura","volume":"6","author":"Eknoyan","year":"1986","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00005792-198111000-00003","article-title":"Thrombotic thrombocytopenic purpura: report of 25\u00a0cases and a review of the literature","volume":"60","author":"Ridolfi","year":"1981","journal-title":"Medicine"},{"key":"10.1016\/j.nephro.2010.03.002_bib54","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0002-9343(78)90818-5","article-title":"Respiratory dysfunction in thrombotic thrombocytopenic purpura","volume":"65","author":"Bone","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0022-3476(82)80749-X","article-title":"Development of insulin-dependent diabetes mellitus during the hemolytic-uremic syndrome","volume":"100","author":"Andreoli","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.nephro.2010.03.002_bib56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-3476(83)80782-3","article-title":"Acute rhabdomyolysis associated with haemolytic-uremic syndrome","volume":"103","author":"Andreoli","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.nephro.2010.03.002_bib57","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/ndt\/17.7.1228","article-title":"Adult haemolytic and uraemic syndrome: causes and prognostic factors in the last decade","volume":"17","author":"Tostivint","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.03.002_bib58","first-page":"287","article-title":"Thrombotic thrombocytopenic purpura: a review","volume":"6","author":"Bukowski","year":"1982","journal-title":"Prog Hemost Thromb"},{"key":"10.1016\/j.nephro.2010.03.002_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0308-2261(18)30024-9","article-title":"Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy","volume":"15","author":"Byrnes","year":"1986","journal-title":"Clin Hematol"},{"key":"10.1016\/j.nephro.2010.03.002_bib60","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1182\/blood.V60.3.564.564","article-title":"Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet \u201cexhaustion\u201d","volume":"60","author":"Fong","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.03.002_bib61","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(73)92782-7","article-title":"Serum complement levels in haemolytic-uraemic syndrome","volume":"2","author":"Kaplan","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2010.03.002_bib62","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/ndt\/13.1.76","article-title":"Haemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura in adults: clinical findings and prognostic factors for death and end stage renal disease","volume":"13","author":"Hollenbeck","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"(suppl) 1","key":"10.1016\/j.nephro.2010.03.002_bib63","first-page":"27","article-title":"Adult hemolytic uremic syndrome with renal microangiopathy. Outcome according to therapeutic protocol in 53\u00a0cases","volume":"143","year":"1992","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.nephro.2010.03.002_bib64","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/ki.1979.70","article-title":"Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome) clinicopathologic study in 20\u00a0adults","volume":"15","author":"Morel-Maroger","year":"1979","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.03.002_bib65","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ki.1992.62","article-title":"The diagnostic yield of transjugular renal biopsy. Experience in 200\u00a0cases","volume":"41","author":"Mal","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.03.002_bib66","first-page":"101","article-title":"Role of fibrinolysis in thrombotic thrombocytopenic purpura","volume":"24","author":"Kwaan","year":"1987","journal-title":"Semin Hematol"},{"key":"10.1016\/j.nephro.2010.03.002_bib67","first-page":"55","article-title":"Plasminogen activator inhibitor in renal fibrin deposits of human nephropathies","volume":"33","author":"Rondeau","year":"1990","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib68","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0049-3848(85)90180-X","article-title":"Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen","volume":"38","author":"Asada","year":"1985","journal-title":"Thromb Res"},{"key":"10.1016\/j.nephro.2010.03.002_bib69","first-page":"193","article-title":"Hemolytic uremic syndrome with hypocomplementemia and deposits of IgM and C3\u00a0in the involved renal tissue","volume":"16","author":"Gonzalo","year":"1981","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib70","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/blood.V40.3.416.416","article-title":"Thrombotic thrombocytopenic purpura: report of a case with possible immune etiology","volume":"40","author":"Mant","year":"1972","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.03.002_bib71","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","article-title":"The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157: H7\u00a0infections","volume":"342","author":"Wong","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib72","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood.V96.4.1223","article-title":"How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"96","author":"Georges","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.03.002_bib73","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00858677","article-title":"Treatment of the childhood haemolytic uraemic syndrome with plasma: a multicentre randomized controlled trial","volume":"2","author":"Loirat","year":"1988","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00008480-200002000-00005","article-title":"Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"12","author":"Baker","year":"2000","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.nephro.2010.03.002_bib76","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(99)01251-9","article-title":"Effectiveness of therapeutic exchange in the 1996\u00a0Lanarkshire Escherichia coli O157: H7\u00a0outbreak","volume":"354","author":"Dundas","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2010.03.002_bib77","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.03.002_bib78","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108\u00a0patients","volume":"325","author":"Bell","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.nephro.2010.03.002_bib79","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic-uremic syndrome","volume":"360","author":"N\u00fcrnberger","year":"2009","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1016\/j.nephro.2010.03.002_bib80","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMc0809959","article-title":"Eculizumab for congenital atypical hemolytic-uremic syndrome","volume":"360","author":"Gruppo","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nephro.2010.03.002_bib81","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1128\/JCM.38.9.3404-3406.2000","article-title":"Comparison of Escherichia coli O157:H7\u00a0antigen detection in stool and broth cultures to that in sorbitol-MacConkey agar stool cultures","volume":"38","author":"Stapp","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.nephro.2010.03.002_bib82","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/ndt\/16.4.846","article-title":"Renal thrombotic microangiopathie induced by interferon","volume":"16","author":"Badid","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.03.002_bib83","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/00007611-200093070-00021","article-title":"Quinine-induced hemolytic-uremic syndrome","volume":"93","author":"Crum","year":"2000","journal-title":"South Med J"},{"key":"10.1016\/j.nephro.2010.03.002_bib84","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<2023::AID-CNCR21>3.0.CO;2-2","article-title":"A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy","volume":"85","author":"Fung","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.nephro.2010.03.002_bib85","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/ndt\/14.6.1578","article-title":"Acute renal failure in the course of HIV infection: a single-institution retrospective study of ninety-two patients and sixty renal biopsies","volume":"14","author":"Peraldi","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.03.002_bib86","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2141.2001.02808.x","article-title":"Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of vonWillebrand factor-cleaving protease","volume":"113","author":"Barbot","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.nephro.2010.03.002_bib87","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1681\/ASN.2005010086","article-title":"Complement factor H mutation in familial thrombotic thrombocytopenic purpura with DAMTS13\u00a0deficiency and renal involvement","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib88","first-page":"119","article-title":"Thrombotic microangiopathy in pregnancy and the postpartum period","volume":"24","author":"Weiner","year":"1987","journal-title":"Semin Hematol"},{"key":"10.1016\/j.nephro.2010.03.002_bib89","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/01.AOG.0000258281.22296.de","article-title":"Imitators of severe preeclampsia","volume":"109","author":"Sibai","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.nephro.2010.03.002_bib90","first-page":"503","article-title":"Insuffisances r\u00e9nales aigu\u00ebs gravidiques et du post-partum","volume":"27","author":"Kanfer","year":"1977","journal-title":"Rev Prat"},{"issue":"12","key":"10.1016\/j.nephro.2010.03.002_bib91","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1182\/blood-2008-03-144691","volume":"112","author":"Fakhouri","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.nephro.2010.03.002_bib92","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2007-994923","article-title":"Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura: hemolytic uremic syndrome in the cancer patient","volume":"25","author":"Gordon","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.nephro.2010.03.002_bib93","first-page":"265","article-title":"Hemolytic uremic syndrome in a patient with gastric adenocarcinoma: partial recovery of renal function after gastrectomy","volume":"24","author":"Ortega Marcos","year":"1985","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib94","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/jcp.24.5.456","article-title":"Microangiopathic haemolytic anaemia associated with malignant haemangio-endothelioma","volume":"24","author":"Donald","year":"1971","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.nephro.2010.03.002_bib95","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1634\/theoncologist.12-1-11","article-title":"Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10\u00a0patients and a systematic review of published cases","volume":"12","author":"Francis","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.nephro.2010.03.002_bib96","first-page":"161","article-title":"Thrombotic microangiopathy in cancer patient including those induced by chemotherapeutic agents","volume":"24","author":"Murgo","year":"1987","journal-title":"Semin Hematol"},{"key":"10.1016\/j.nephro.2010.03.002_bib97","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/CCO.0b013e3280148a2f","article-title":"Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Kojouri","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.nephro.2010.03.002_bib98","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.nephro.2010.03.002_bib99","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2141.2006.06126.x","article-title":"Prospective study on the behaviour of the metalloprotease ADAMTS13\u00a0and of von Willebrand factor after bone marrow transplantation","volume":"134","author":"Peyvandi","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.nephro.2010.03.002_bib100","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/01.TP.0000141363.81600.0D","article-title":"Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion","volume":"78","author":"Hahn","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2010.03.002_bib101","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0272-6386(99)70269-6","article-title":"Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome","volume":"33","author":"Gisselbrecht","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.03.002_bib102","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00007890-199902270-00009","article-title":"FK-506-associated thrombotic microangiopathy","volume":"67","author":"Trimarchi","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2010.03.002_bib103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(07)70037-2","article-title":"Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma","volume":"8","author":"Frangi\u00e9","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nephro.2010.03.002_bib104","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ncpneph0476","article-title":"Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma","volume":"3","author":"Roncone","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.nephro.2010.03.002_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197401000-00001","article-title":"The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation","volume":"53","author":"Cannon","year":"1974","journal-title":"Medicine"},{"key":"10.1016\/j.nephro.2010.03.002_bib106","series-title":"N\u00e9phrologie","first-page":"650","article-title":"Le rein de la scl\u00e9rodermie.","author":"Cannon","year":"1979"},{"key":"10.1016\/j.nephro.2010.03.002_bib107","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0021-9681(73)90054-4","article-title":"Survival with scleroderma. Il. A life table analysis of clinical and demographic factors in 358\u00a0male US veteran patients","volume":"26","author":"Medsger","year":"1973","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.nephro.2010.03.002_bib108","first-page":"594","article-title":"Atteintes r\u00e9nales des scl\u00e9rodermies","volume":"135","author":"Richet","year":"1984","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.nephro.2010.03.002_bib109","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis","volume":"76","author":"Steen","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib110","doi-asserted-by":"crossref","first-page":"642","DOI":"10.7326\/0003-4819-89-5-642","article-title":"Reversal of severe renal failure in systemic sclerosis","volume":"89","author":"Lam","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib111","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM197906213002505","article-title":"Reversal of vascular and renal crisis of scleroderma by oral angiotensin converting enzyme blockade","volume":"300","author":"Lopez Ovejero","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib112","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0002-9610(77)90170-2","article-title":"Renal transplantation for progressive systemic sclerosis with renal failure. Case report and review of previous experience","volume":"133","author":"Merino","year":"1977","journal-title":"Am J Surg"},{"key":"10.1016\/j.nephro.2010.03.002_bib113","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0002-9343(79)90807-6","article-title":"Resolution of renal failure with malignant hypertension in scleroderma. Case report and review of the literature","volume":"67","author":"Simon","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2010.03.002_bib114","first-page":"165","article-title":"Hemolytic and uremic syndrome in the adult","volume":"23","author":"Vigneau","year":"2002","journal-title":"Nephrologie"},{"key":"10.1016\/j.nephro.2010.03.002_bib115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ki.1983.29","article-title":"Abnormalities of renin-containing cells in human glomerular and vascular renal diseases","volume":"23","author":"Nochy","year":"1983","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.03.002_bib116","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.semarthrit.2006.01.001","article-title":"Antiphospholipid syndrome and the kidneys","volume":"35","author":"Uthman","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.nephro.2010.03.002_bib117","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","article-title":"Thrombotic microangiopathy after renal transplantation in the United States","volume":"42","author":"Reynolds","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.03.002_bib118","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00005792-200003000-00003","article-title":"Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Coop\u00e9ratif de l\u2019Ile-de-France","volume":"79","author":"Lahlou","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.nephro.2010.03.002_bib119","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00467-003-1289-8","article-title":"The risk of recurrence of haemolytic uremic syndrome after renal transplantation in children","volume":"18","author":"Loirat","year":"2003","journal-title":"Pediatr Nephrol"}],"container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725510000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725510000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2010.03.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:44:11Z","timestamp":1741185851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725510000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1769725510000507"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2010.03.002","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}